Prospective study evaluates methylated SEPT9 blood testing in asymptomatic populations, suggesting a new pathway to improve colorectal cancer screening uptake.
As screening methods for colorectal cancer (CRC) are limited by uptake and adherence, further options are sought. A blood test might increase both, but none has yet been tested in a screening setting.
No takes yet. Share an insight, caveat, or question.
Day et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: